Medtronic plc (MDTC34) - Total Liabilities
Based on the latest financial reports, Medtronic plc (MDTC34) has total liabilities worth R$42.50 Billion BRL (≈ $8.34 Billion USD) as of January 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Medtronic plc - Total Liabilities Trend (2019–2025)
This chart illustrates how Medtronic plc's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Medtronic plc to evaluate short-term liquidity relative to the company's equity base.
Medtronic plc Competitors by Total Liabilities
The table below lists competitors of Medtronic plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Howmet Aerospace Inc
NYSE MKT:HWM
|
USA | $7.54 Billion |
|
Sanofi
F:SNW2
|
Germany | €56.26 Billion |
|
Mizuho Financial Group Inc.
NYSE:MFG
|
USA | $286.31 Trillion |
|
GlaxoSmithKline plc
MX:GSKN
|
Mexico | MX$45.59 Billion |
|
Canadian Imperial Bank Of Commerce
TO:CM
|
Canada | CA$1.09 Trillion |
|
Accenture plc
NYSE:ACN
|
USA | $32.78 Billion |
|
Marriott International Inc
NASDAQ:MAR
|
USA | $31.95 Billion |
|
Bank of Nova Scotia
TO:BNS
|
Canada | CA$1.39 Trillion |
Liability Composition Analysis (2019–2025)
This chart breaks down Medtronic plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MDTC34 company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.54 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.12 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.87 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medtronic plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medtronic plc (2019–2025)
The table below shows the annual total liabilities of Medtronic plc from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-04-30 | R$43.42 Billion ≈ $8.52 Billion |
+9.20% |
| 2024-04-30 | R$39.77 Billion ≈ $7.80 Billion |
+0.77% |
| 2023-04-30 | R$39.47 Billion ≈ $7.74 Billion |
+3.15% |
| 2022-04-30 | R$38.26 Billion ≈ $7.51 Billion |
-7.77% |
| 2021-04-30 | R$41.48 Billion ≈ $8.14 Billion |
+4.18% |
| 2020-04-30 | R$39.82 Billion ≈ $7.81 Billion |
+0.85% |
| 2019-04-30 | R$39.48 Billion ≈ $7.75 Billion |
-- |
About Medtronic plc
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor sy… Read more